Latest in Cardiology from ACC.org

• ACC Releases Expert Consensus Decision Pathway on TR Evaluation and Management
  The ACC has released a new Expert Consensus Decision Pathway (ECDP) addressing "10 issues for the clinician in tricuspid regurgitation (TR) evaluation and management."
• Top Posters at ACC Latin America 2025 Explore Myocardial Contraction Fraction, Vericiguat in HFrEF, Long COVID
  As hundreds of participants gathered to share and learn about the latest science from the Latin America region, the top three posters from ACC Latin America 2025 earned a spot to present at ACC.26 in New Orleans, LA.
• Intensive BP Control Provides Net Benefit Between Fewer CV and More Adverse Events
  Intensive blood pressure (BP) control compared with standard BP control offers a net benefit between the decrease in cardiovascular events and increase in adverse events, including kidney-related events, according to a meta-analysis published Sept. 6 in The Lancet.
• Partial Heart Transplant Viable Option For Children With Congenital Valve Disease
  Partial heart transplant provides a safe and effective valve replacement alterative with the capacity for valve growth in children with congenital heart disease, decreasing the need for reoperation, according to a small retrospective study published Aug. 27 in JAMA.
• Clopidogrel Superior to Aspirin For Prevention of MACCE in Patients With CAD
  Clopidogrel monotherapy is superior to aspirin monotherapy for prevention of major adverse cardiovascular or cerebrovascular events (MACCE) without increasing major bleeding risk and supports the use of clopidogrel over aspirin for secondary prevention in patients with coronary artery disease (CAD)...